Evaluating the Safety of Combined Ipilimumab and Radiotherapy for the Treatment of Metastatic Melanoma

被引：0
|
作者：
Postow, Michael A. [1 ]
Barker, Christopher A. [1 ]
Khan, Shaheer A. [1 ]
Wolchok, Jedd D. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF IMMUNOTHERAPY | 2012年 / 35卷 / 09期
关键词：
Melanoma immunotherapy; Abscopal; CTLA-4;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：733 / 733
页数：1
相关论文
共 50 条
  • [31] Acute Cholecystitis Following Ipilimumab and Nivolumab Treatment for Metastatic Melanoma
    Somerset, Amy E.
    Field, Bradley M.
    Webber, John D.
    Edelman, David A.
    AMERICAN SURGEON, 2023, 89 (02) : 312 - 313
  • [32] Widespread biphasic amyloidosis related to ipilimumab treatment for metastatic melanoma
    Velasco-Tamariz, Virginia
    Prieto-Barrios, Marta
    Tous-Romero, Fatima
    Burillo-Martinez, Sara
    Morales-Raya, Carlos
    Aragon-Miguel, Raquel
    Ortiz-Romero, Pablo
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB283 - AB283
  • [33] Ipilimumab compassive treatment of metastatic melanoma in Mexico: a case series
    Angel Alvarez-Avitia, Miguel
    Garcia-Pinzon, Sheyla
    Luis Gonzalez-Trujillo, Jose
    Villalobos-Prieto, Alberto
    Rodriguez-Abrajan, Gerardo
    Matus-Santos, Juan
    GACETA MEXICANA DE ONCOLOGIA, 2014, 13 (02): : 112 - 116
  • [34] Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma
    Sander Kelderman
    Bianca Heemskerk
    Harm van Tinteren
    Rob R. H. van den Brom
    Geke A. P. Hospers
    Alfonsus J. M. van den Eertwegh
    Ellen W. Kapiteijn
    Jan Willem B. de Groot
    Patricia Soetekouw
    Rob L. Jansen
    Edward Fiets
    Andrew J. S. Furness
    Alexandra Renn
    Marcin Krzystanek
    Zoltan Szallasi
    Paul Lorigan
    Martin E. Gore
    Ton N. M. Schumacher
    John B. A. G. Haanen
    James M. G. Larkin
    Christian U. Blank
    Cancer Immunology, Immunotherapy, 2014, 63 : 449 - 458
  • [35] Widespread biphasic amyloidosis related to ipilimumab treatment for metastatic melanoma
    Velasco-Tamariz, Virginia
    Burillo-Martinez, Sara
    Prieto-Barrios, Marta
    Calleja-Algarra, Alba
    Rodriguez-Peralto, Jose L.
    Ortiz-Romero, Pablo L.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2017, 56 (09) : E189 - E191
  • [36] Evaluation of Treatment Response to Ipilimumab in Patients with metastatic malignant Melanoma
    Rudolph, B. M.
    Mueller-Brenne, T.
    Groffik, A.
    Wilden, S.
    Grabbe, S.
    Loquai, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 (09): : 930 - 931
  • [37] Partial Remission of metastatic Malignant melanoma after Treatment with Ipilimumab
    Liakou, Aikaterini I.
    Trebing, Dietrich
    Zouboulis, Christos C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 : 9 - 9
  • [38] Treatment of a patient with HIV and metastatic melanoma with consequitive ipilimumab and nivolumab
    Tomsitz, D.
    Hein, R.
    Biedermann, T.
    Kohlmeyer, J.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (01) : E26 - E28
  • [39] Treatment of Ipilimumab Induced Graves' Disease in a Patient with Metastatic Melanoma
    Azmat, Umal
    Liebner, David
    Joehlin-Price, Amy
    Agrawal, Amit
    Nabhan, Fadi
    CASE REPORTS IN ENDOCRINOLOGY, 2016, 2016
  • [40] Acute visual loss after ipilimumab treatment for metastatic melanoma
    Wilson, Melissa A.
    Guld, Kelly
    Galetta, Steven
    Walsh, Ryan D.
    Kharlip, Julia
    Tamhankar, Madhura
    McGettigan, Suzanne
    Schuchter, Lynn M.
    Fecher, Leslie A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2016, 4
12345